Affiliations

NYBA

Australia Biotech

BioMelbourne

Lab To Wall Street

Industry News

Browse news archive by:
Date | Company Name | Country/States

A:

Avantogen

B:

BioDiem Limited
Bionomics Limited
Biosignal
Biotech Capital
Bone Medical Limited
Bovagen Biologicals
BresaGen Limited
BTF

C:

ChemGenex Pharmaceuticals
C3 (Clinical Cell Culture Limited)
CordLife Pty. Limited
CogState Limited
Cryptome Pharmaceuticals
CyGenics Limited
Cytopia Limited

E:

Epitan Limited
EQiTX Limited
EvoGenix Limited

F:

Fluorotechnics Pty Limited

G:

Genetics Technologies Limited
Glykoz Limited

I:

Iatia

L:

Living Cell Technology

M:

Meditech Research Limited
Mesoblast Limited
Metabolic Pharmaceuticals Limited

N:

Nanomics BioSystems
Neuren Pharmaceuticals Limited

P:

Pharmaxis
PolyNovo Biomaterials Pty Limited
Prima Biomed
Progen Industries Limited
Pro Medicus Limited
Proteome Systems
Phylogica Limited
pSivida Limited

R:

Regenera Limited
Resonance Health Limited
Ritract Limited
Rockeby Biomed Limited

S:

Solagran
Solbec Pharmaceuticals
SSH Medical
Starpharma Holdings Limited
Stem Cell Sciences Limited

V:

VacTX Pty Limited
Ventracor Limited
Visiomed

X:

XRT Limited

  May 28th, 2009:
Arana Therapeutics Board Changes

May 6th, 2009:
Circadian Scientific Advisory Board Chairman, Professor Kari Alitalo, Wins Prestigious Award for Biomedical Research

May 5th, 2009:
Living Cell Technologies Reports Insulin Independence in Two Patients Following Recent Implants of DIABECELL® in Diabetes Clinical Trial

November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

August 6th:
Xenome Strengthens Board with Two New Appointments

August 6th:
Ciba Elects to Cease Industrial Product Evaluations

June 24th:
New Pharmaxis Board Appointment

April 29th:
Benitec secures further rights to HIV Therapeutic

more industry news >
 


osullivanpllc.com  

Disclaimer